List view / Grid view
30 August 2018 | By Daniela Cavagnino
Pharmaceutical products come into contact with a wide range of polymeric materials on their journey from the production line to patients. Plastic and rubber contact surfaces are present at almost every stage of a product’s lifecycle: they’re present in single-use systems, such as filters and tubing employed in manufacturing processes;…
30 August 2018 | By European Pharmaceutical Review
In this issue: Anastasia Petropoulu focuses on some of the Pharmaceutical Quality Systems in relation to QA of manufactured medicines, and Dave Elder looks at method/process capability in terms of QA/QC.
29 August 2018 | By European Pharmaceutical Review
In this issue: the importance of culture media selection, control and realease, how the new draft of Annex 1, Manufacture of Sterile Medicinal Products is impacting environmental monitoring programmes, and software tools that enable confident GC-MS analysis of extractables in pharmaceutical products.
29 August 2018 | By European Pharmaceutical Review
In this issue: investment in biopharmaceuticals, particle size methods, and unlocking the potential of new technologies like Lab-on-a-chip.
29 August 2018 | By European Pharmaceutical Review
A US perspective on how pharma companies are preparing for Brexit, overcoming disinfectant residues with culture media neutralisers, unlocking the potential of new technology in biopharma, and much more in this issue of European Pharmaceutical Review.
19 July 2018 | By Dave P Elder, Mike Stones
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
9 July 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
As part of EPR’s Women inspiring Pharma series, Gowri Sukumar, Associate Director, CMC and Regulatory Affairs at ESSA Pharmaceuticals, talks to Science Editor Dr Zara Kassam about having a positive mindset, diversity and the key to success…
3 July 2018 | By European Pharmaceutical Review
This supplement brings together leading companies with compelling science stories to share in a simple-to-understand format.
27 June 2018 | By European Pharmaceutical Review
This issue recaps the Joint Pharmaceutical Analysis Group's symposium on Continuous Manufacturing, and explores the "perfect technology storm" facing the pharmaceutical sector.
26 June 2018 | By European Pharmaceutical Review
In this issue: the role of bioptherapeutics in curing a range of diseases, and is supercritical fluid chromatography applicable to achiral separations?
25 June 2018 | By European Pharmaceutical Review
In this issue: the applications of vibrational spectroscopy for analysing the molecular component of a solid sample, and Raman as a fast-growing tool for PAT/QbD
22 June 2018 | By European Pharmaceutical Review
In this issue: Microfluidics technology in pharmaceutical research, drug manufacturing and development, and is supercritical fluid chromatography applicable to achiral separations?
18 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
As part of EPR’s Women inspiring Pharma series, Liz Barrett, CEO Oncology, Novartis, talks to Science Editor Dr Zara Kassam about finding cures for cancer, identifying meaningful partnerships and acknowledging unconscious biases…
7 June 2018 | By European Pharmaceutical Review
The General Data Protection Regulation (GDPR) is a new set of EU rules governing how a company manages, protects and administers personal data. Whether you are a subscriber, author, advertiser or supplier to our journal, we may hold information about you and we need to keep it private and secure.
23 May 2018 | By Lars Decker Nielsen, Naja Wessel Jacobsen
Two-dimensional liquid chromatography (2D-LC) has obtained increasing focus over the past two decades. At LEO Pharma, we continuously evaluate new laboratory techniques with the potential to advance our drug discovery and development. We installed a MHC 2D-LC 18 months ago and have found it valuable in a broad range of…
Follow: